The global arthroscopy visualization systems market was about US$ 427.3 Million in 2021, with the global market estimated to surge ahead at a CAGR value of 7.1% to reach a valuation of US$ 902.5 Million by the end of 2032. The visualization systems are driving the global arthroscopy visualization systems market as of 2021.
Market Outlook:
| Data Points | Market Insight |
|---|---|
| Market Value 2021 | US$ 427.3 Million |
| Estimated market Value 2022 | US$ 453.8 Million |
| Estimated market Value 2032 | US$ 902.5 Million |
| CAGR of 2022 to 2032 | 7.1 % |
| Market share of Top 5 countries | 60.9 % |
| Key Market players | Arthrex, Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, Johnson & Johnson |
Arthroscopes are thin fiber-optic scopes that enable visualization of the interior of joints, such as the knee, shoulder, wrist, hip, ankle, and elbow. The arthroscopic system is used in the minimally-invasive surgical procedures.
Arthroscopy is a minimally invasive surgery used to detect and treat joint problems. It permits a surgeon to view the joint without having to make a sizable incision. At a specific point during arthroscopy, surgeons can even repair joint damage using pencil-thin surgical instruments inserted through extremely small incisions.
In this operation, the surgeon makes a tiny incision and inserts a skinny tube with a fiber-optic video camera inside. A high-definition video display receives the view from inside the joint.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Overall, arthroscopy visualization systems market sales account for approximately 6.6% revenue share in the global arthroscopy products market, which was valued at around US$ 6.5 Billion, in 2021.
The global arthroscopy visualization systems market recorded a historic CAGR of 5.1% in the last nine years from 2012 to 2021.
One of the main factors driving the growth of the global market for arthroscopy visualization systems is the increase in the elderly population, who are considerably more susceptible to trauma, osteoarthritis, and other knee and joint-related disorders. Soft tissue degeneration and associated problems, particularly those of the knee, are influenced by aging. The elderly population makes up more than one-third of all hip and shoulder injuries worldwide.
For instance, the World Health Aging 2020 highlights published by the UN Department of Economic and Social Affairs indicated that there were 727 million individuals who were either 65 or older worldwide in October 2020, making up 9.3% of the entire world's population. By 2050, the aging population is projected to grow by 16% or over 1.5 billion people.
Furthermore, the development of technologically advanced instruments, implants, and equipment for arthroscopy surgeries with arthroscopy visualization systems will foster growth worldwide, as will the rising number of arthroscopic procedures as a result of the rise in sports injuries, ligament tears, meniscus tears, and other similar reasons.
Osteoarthritis is more common in the elderly and obese population, which will raise the demand for arthroscopy visualization systems. The Centers for Disease Control and Prevention (CDC) estimated that in 2015, osteoarthritis impacted 32.5 million individuals in the United States and about 54.4 million people overall.
By 2040, this figure is projected to increase to 78 million. Obesity triples the likelihood of developing knee osteoarthritis, making it a significant risk factor.
The aforementioned factors are expected to serve as probable market drivers for the global arthroscopy visualization systems market and help the market to expand significantly in the forecast period.
Due to the numerous advantages that minimally invasive surgical procedures have over open surgeries, including small surgical incisions, lower hospitalization costs, and fewer post-operative complications, minimally invasive surgeries are becoming increasingly popular among surgeons.
The market for arthroscopy visualization systems is likely to see significant growth potential due to rising preference and acceptance of minimally invasive and cost-effective procedures employing arthroscopic instruments.
Opportunities for developing technologies like improvised visualization equipment in the form of high-definition cameras or autoclavable cameras, and improved suturing techniques, are projected to arise from the growth of sports injuries and medicine, particularly arthroscopy.
Additionally, advanced technologies in hip arthroscopies, such as computer-assisted surgeries and virtual reality surgical simulation training before actual operations, have increased the precision of pre-operative planning and are anticipated to broaden the scope of hip arthroscopy, which will favorably impact the market for arthroscopy visualization systems.
The abovementioned factors are capable of acting as lucrative opportunities for manufacturers operating in the arthroscopy visualization systems market.
Principal Consultant
The market for arthroscopy visualization systems and products was negatively impacted by the coronavirus outbreak. Due to cancellations of planned operations at various medical facilities, due to travel limitations that have an impact on logistics and product supply, there has been an increase in interruptions at production sites, in the supply chain, and in other commercial activities.
A rise in product recalls is one of the reasons restricting the market for arthroscopy visualization systems. A product recall is a process of collecting every faulty item that has been sold or is currently on the market.
The expenses of all repairs and replacements must be covered by the manufacturer when it recalls a product because of a problem. The replacement cost for many products could be in the millions of dollars, which limits the market's growth as well as that of a company.
For instance, in Jan 2022, the FDA recalled a product called Camera Control Unit (CCU) of Stryker Corporation on the charge of medical safety notification January. The images on the monitor obtained were upside-down in the wrong position due to a software flaw in the camera control unit (CCU). Conversion to an open operation, extra medical treatment, or revision surgery all included the risk of negative outcomes.
The USA accounted for US$ 137.3 Million withholding the majority of the global market share of about 32.1% by the end of 2021. The American Orthopedic Society for Sports Medicine, the Arthritis Foundation, and the Arthroscopy Association of USA are a few of the organizations that receive major funding and assistance from the USA Federal Government for orthopedic care and treatment.
Due to the USA FDA's supportive environment and the country's manufacturers' extensive Drivers, Restraints, Opportunities, and Threats efforts, the USA is the largest market in the world for arthroscopy visualization systems.
Germany has driven the European market by holding the majority of the regional market share of about 33.9% and achieving a valuation of US$ 45.9 Million at end of 2021. The market is being driven by an increase in the number of urgent care patients with long-term illnesses, an increase in Level 3 grade injuries among the aging population & athletes, and an increase in the number of accidents countrywide.
The market for arthroscopy visualization systems is anticipated to develop as a result of the increasing incidence of hip and spine surgeries.
China dominated the regional market by reaching a valuation of US$ 22.66 Million and is expected to grow over a CAGR of 8.5% over the forecast period. The market’s expansion can be attributed to the country's growing medical tourism industry.
The market in China is also anticipated to be driven by a rising aging population, increased awareness of sports-related injuries, and rising disposable income. The global market for arthroscopy visualization is expanding as a result of rising demand for minimally invasive procedures and low levels of postoperative complications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product, the visualization systems have driven the global market by holding the majority of the market share of about 48.8% as of 2021. Smaller incisions, lower soft tissue trauma, less post-operative discomfort, quicker healing times, and lower infection rates are some of the aspects that contribute to the product’s market expansion.
By application, knee arthroscopy is leading the segment for the global market by accounting for US$ 131.0 Million by the end of 2021. With the increasing geriatric population, bone-related issues are also emerging, especially the rising prevalence of osteoarthritis, as well as an increasing number of sports-related injuries, which have driven this segment.
By end user, orthopedic clinics have led the global market by holding a majority of the market share of about 31.1% as of 2021. The availability of advanced healthcare infrastructure and the presence of a large patient pool are some of the major factors contributing to the market growth of orthopedic centers.
The expansion of manufacturing facilities is a top priority for manufacturers of arthroscopy visualization systems since it will increase their production capacity. the exploration of new markets and access to a sizable customer base, will offer companies prospects for expansion on a global scale.
To strengthen their position in the global market for arthroscopy visualization systems, the major manufacturers are launching a variety of products and doing research and development activities that concentrate on orthopedic surgical procedures.
For instance:
Similarly, recent developments related to companies manufacturing arthroscopy visualization systems, have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2012 to 2021 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa (MEA). |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Application, End User, and Regions |
| Key Companies Profiled | Arthrex, Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, and Johnson & Johnson |
| Pricing | Available upon Request |
The global arthroscopy visualization systems market is worth US$ 427.3 Million at end of 2021.
The arthroscopy visualization systems market is expected to reach US$ 902.5 Million by end of 2032 at a CAGR of 7.1%.
Technological advancements in arthroscopy visualization systems, and increasing bone and joint-related issues among people, leading to an increase in the prevalence of arthritis and chronic illness, are some of the key factors that drive this market.
The North American region has the highest market share of about 34.1% by the end of 2021 in the global arthroscopy visualization systems market.
India accounted for about 3.9% of the global market share in the 2021 arthroscopy visualization systems market.
The USA, China, Germany, the United Kingdom, and India are the top five countries, which are expected to drive demand in the arthroscopy visualization systems market.
Arthrex Inc., Stryker Corporation, Smith & Nephew Plc., CONMED Corporation, KARL STORZ GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, and Johnson & Johnson, are some of the key players in the arthroscopy visualization systems industry.
From 2012 to 2021, the market for arthroscopy visualization systems devices expanded at the rate of 5.1%.
China accounted for 55.6% of the market share at the end of 2021 in the East Asian market.
Germany displayed a market share of around 33.9% in 2021 in the European arthroscopy visualization systems market.
1. Executive Summary | Arthroscopy Visualization Systems Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmaps 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Disease Epidemiology, by Region 4.2. Key Promotional Strategies By Manufacturers 4.3. Value Chain Analysis 4.4. Reimbursement Scenario 4.5. Regulatory Approval 4.6. Product Adoption Analysis 4.7. Installed Based Scenario 4.8. PESTEL Analysis 4.9. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Outlook 5.1.3. Global Arthroscopy Products Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Cost of Visualization Systems 5.2.3. Demand for Arthroscopy Procedures 5.2.4. Availability of the Better Healthcare Infrastructure 5.2.5. Prevalence of Arthritis 5.2.6. Growing Awareness About Bone Health 5.2.7. Government Funding 5.2.8. Rising Geriatric Population 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By End User 6.1.4. By Country 6.2. 2021 Market Scenario 7. Global Market Volume (Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (Units) Analysis, 2012 to 2021 7.2. Current and Future Market Volume (Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis, by Products 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Demand (in Value US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032 9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021 9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Product, 2012 to 2021 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, by Product, 2022 to 2032 10.3.1. Arthroscopes 10.3.2. Visualization Systems 10.3.3. Consumables & Accessories 10.4. Market Attractiveness Analysis, by Product 11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis, by Product, 2012 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Product, 2022 to 2032 11.3.1. Knee Arthroscopy 11.3.2. Hip Arthroscopy 11.3.3. Shoulder Arthroscopy 11.3.4. Others 11.4. Market Attractiveness Analysis, by Application 12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2021 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by End User, 2022 to 2032 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Orthopedic Clinics 12.3.4. Others 12.4. Market Attractiveness Analysis, by End User 13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2012 to 2021 13.3. Current and Future Market Value (US$ Million) and Volume (Units) Projections, 2022 to 2032 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis, by Region 14. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 14.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Market Trends 14.6. Drivers and Restraints - Impact Analysis 14.7. Country-Level Analysis & Forecast 14.7.1. USA Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By Application 14.7.1.2.3. By End User 14.7.2. Canada Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By Application 14.7.2.2.3. By End User 15. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 15.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 15.3.1. By Country 15.3.1.1. Mexico 15.3.1.2. Brazil 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Market Trends 15.6. Drivers and Restraints - Impact Analysis 15.7. Country-Level Analysis & Forecast 15.7.1. Mexico Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By Application 15.7.1.2.3. By End User 15.7.2. Brazil Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By Application 15.7.2.2.3. By End User 15.7.3. Argentina Market Analysis 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy 15.7.3.2.1. By Product 15.7.3.2.2. By Application 15.7.3.2.3. By End User 16. Europe Market Analysis 2012 to 2021 and Forecast 2022 to 2032 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 16.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Market Trends 16.6. Drivers and Restraints - Impact Analysis 16.7. Country-Level Analysis & Forecast 16.7.1. Germany Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By Application 16.7.1.2.3. By End User 16.7.2. Italy Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By Application 16.7.2.2.3. By End User 16.7.3. France Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By Application 16.7.3.2.3. By End User 16.7.4. United Kingdom Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By Application 16.7.4.2.3. By End User 16.7.5. Spain Market Analysis 16.7.5.1. Introduction 16.7.5.2. Market Analysis and Forecast, by Market Taxonomy 16.7.5.2.1. By Product 16.7.5.2.2. By Application 16.7.5.2.3. By End User 16.7.6. BENELUX Market Analysis 16.7.6.1. Introduction 16.7.6.2. Market Analysis and Forecast, by Market Taxonomy 16.7.6.2.1. By Product 16.7.6.2.2. By Application 16.7.6.2.3. By End User 16.7.7. Russia Market Analysis 16.7.7.1. Introduction 16.7.7.2. Market Analysis and Forecast, by Market Taxonomy 16.7.7.2.1. By Product 16.7.7.2.2. By Application 16.7.7.2.3. By End User 17. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 17.1. Introduction 17.2. Historical Market Distribution Channel (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 17.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Market Trends 17.6. Drivers and Restraints - Impact Analysis 17.7. Country-Level Analysis & Forecast 17.7.1. China Market Analysis 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy 17.7.1.2.1. By Product 17.7.1.2.2. By Application 17.7.1.2.3. By End User 17.7.2. Japan Market Analysis 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy 17.7.2.2.1. By Product 17.7.2.2.2. By Application 17.7.2.2.3. By End User 17.7.3. South Korea Market Analysis 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy 17.7.3.2.1. By Product 17.7.3.2.2. By Application 17.7.3.2.3. By End User 18. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 18.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Indonesia 18.3.1.3. Malaysia 18.3.1.4. Thailand 18.3.1.5. Rest of South Asia 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Market Trends 18.6. Drivers and Restraints - Impact Analysis 18.7. Country-Level Analysis & Forecast 18.7.1. India Market Analysis 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy 18.7.1.2.1. By Product 18.7.1.2.2. By Application 18.7.1.2.3. By End User 18.7.2. Indonesia Market Analysis 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy 18.7.2.2.1. By Product 18.7.2.2.2. By Application 18.7.2.2.3. By End User 18.7.3. Malaysia Market Analysis 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy 18.7.3.2.1. By Product 18.7.3.2.2. By Application 18.7.3.2.3. By End User 18.7.4. Thailand Market Analysis 18.7.4.1. Introduction 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy 18.7.4.2.1. By Product 18.7.4.2.2. By Application 18.7.4.2.3. By End User 19. Oceania Market 2012 to 2021 and Forecast 2022 to 2032 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 19.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Key Market Participants - Intensity Mapping 19.6. Drivers and Restraints - Impact Analysis 19.7. Country-Level Analysis & Forecast 19.7.1. Australia Market Analysis 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy 19.7.1.2.1. By Product 19.7.1.2.2. By Application 19.7.1.2.3. By End User 19.7.2. New Zealand Market Analysis 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy 19.7.2.2.1. By Product 19.7.2.2.2. By Application 19.7.2.2.3. By End User 20. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2012 to 2021 20.3. Current and Future Market Value (US$ Million) and Volume (Unit) Projections, 2022 to 2032 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. North Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By End User 20.5. Market Trends 20.6. Drivers and Restraints - Impact Analysis 20.7. Country-Level Analysis & Forecast 20.7.1. GCC Countries Market Analysis 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast, by Market Taxonomy 20.7.1.2.1. By Product 20.7.1.2.2. By Application 20.7.1.2.3. By End User 20.7.2. Turkey Market Analysis 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast, by Market Taxonomy 20.7.2.2.1. By Product 20.7.2.2.2. By Application 20.7.2.2.3. By End User 20.7.3. South Africa Market Analysis 20.7.3.1. Introduction 20.7.3.2. Market Analysis and Forecast, by Market Taxonomy 20.7.3.2.1. By Product 20.7.3.2.2. By Application 20.7.3.2.3. By End User 20.7.4. North Africa Market 20.7.4.1. Introduction 20.7.4.2. Market Analysis and Forecast, by Market Taxonomy 20.7.4.2.1. By Product 20.7.4.2.2. By Application 20.7.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis, by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Johnson & Johnson 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Sales Footprint 22.3.1.4. Key Financials 22.3.1.5. SWOT Analysis 22.3.1.6. Strategy Overview 22.3.1.6.1. Marketing Strategy 22.3.1.6.2. Product Strategy 22.3.1.6.3. Channel Strategy 22.3.2. Arthrex, Inc. 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Sales Footprint 22.3.2.4. Key Financials 22.3.2.5. SWOT Analysis 22.3.2.6. Strategy Overview 22.3.2.6.1. Marketing Strategy 22.3.2.6.2. Product Strategy 22.3.2.6.3. Channel Strategy 22.3.3. Stryker Corporation 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Sales Footprint 22.3.3.4. Key Financials 22.3.3.5. SWOT Analysis 22.3.3.6. Strategy Overview 22.3.3.6.1. Marketing Strategy 22.3.3.6.2. Product Strategy 22.3.3.6.3. Channel Strategy 22.3.4. Smith & Nephew Plc. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Sales Footprint 22.3.4.4. Key Financials 22.3.4.5. SWOT Analysis 22.3.4.6. Strategy Overview 22.3.4.6.1. Marketing Strategy 22.3.4.6.2. Product Strategy 22.3.4.6.3. Channel Strategy 22.3.5. CONMED Corporation 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Sales Footprint 22.3.5.4. Key Financials 22.3.5.5. SWOT Analysis 22.3.5.6. Strategy Overview 22.3.5.6.1. Marketing Strategy 22.3.5.6.2. Product Strategy 22.3.5.6.3. Channel Strategy 22.3.6. KARL STORZ GmbH & Co. KG 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Sales Footprint 22.3.6.4. Key Financials 22.3.6.5. SWOT Analysis 22.3.6.6. Strategy Overview 22.3.6.6.1. Marketing Strategy 22.3.6.6.2. Product Strategy 22.3.6.6.3. Channel Strategy 22.3.7. Olympus Corporation 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Sales Footprint 22.3.7.4. Key Financials 22.3.7.5. SWOT Analysis 22.3.7.6. Strategy Overview 22.3.7.6.1. Marketing Strategy 22.3.7.6.2. Product Strategy 22.3.7.6.3. Channel Strategy 22.3.8. Richard Wolf GmbH 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Sales Footprint 22.3.8.4. Key Financials 22.3.8.5. SWOT Analysis 22.3.8.6. Strategy Overview 22.3.8.6.1. Marketing Strategy 22.3.8.6.2. Product Strategy 22.3.8.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Arthroscopy Visualization Systems Market
